Values First Advisors Inc. Lowers Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Values First Advisors Inc. cut its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 4.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 26,524 shares of the medical instruments supplier’s stock after selling 1,216 shares during the quarter. LeMaitre Vascular makes up 1.3% of Values First Advisors Inc.’s holdings, making the stock its 13th largest position. Values First Advisors Inc.’s holdings in LeMaitre Vascular were worth $2,444,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. NBC Securities Inc. grew its position in shares of LeMaitre Vascular by 73.2% during the third quarter. NBC Securities Inc. now owns 433 shares of the medical instruments supplier’s stock worth $40,000 after acquiring an additional 183 shares during the last quarter. GAMMA Investing LLC grew its position in shares of LeMaitre Vascular by 34.3% during the third quarter. GAMMA Investing LLC now owns 736 shares of the medical instruments supplier’s stock worth $68,000 after acquiring an additional 188 shares during the last quarter. KBC Group NV grew its position in shares of LeMaitre Vascular by 58.4% during the fourth quarter. KBC Group NV now owns 1,112 shares of the medical instruments supplier’s stock worth $102,000 after acquiring an additional 410 shares during the last quarter. Empowered Funds LLC purchased a new position in shares of LeMaitre Vascular during the fourth quarter worth approximately $150,000. Finally, SG Americas Securities LLC purchased a new position in shares of LeMaitre Vascular during the fourth quarter worth approximately $158,000. 84.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages recently weighed in on LMAT. Cantor Fitzgerald began coverage on LeMaitre Vascular in a report on Tuesday, October 15th. They set a “neutral” rating and a $96.00 price target for the company. Oppenheimer reaffirmed an “outperform” rating and set a $93.00 price target (up from $90.00) on shares of LeMaitre Vascular in a report on Friday, November 1st. Barrington Research increased their price target on LeMaitre Vascular from $92.00 to $93.00 and gave the stock an “outperform” rating in a report on Friday, November 1st. Finally, StockNews.com downgraded LeMaitre Vascular from a “buy” rating to a “hold” rating in a report on Friday, December 13th. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.57.

LeMaitre Vascular Stock Performance

LeMaitre Vascular stock opened at $96.94 on Wednesday. LeMaitre Vascular, Inc. has a one year low of $58.66 and a one year high of $109.58. The business has a fifty day moving average of $96.43 and a two-hundred day moving average of $93.37. The company has a market cap of $2.18 billion, a P/E ratio of 52.97, a price-to-earnings-growth ratio of 2.19 and a beta of 0.96.

Insider Buying and Selling at LeMaitre Vascular

In other news, Director Bridget A. Ross sold 3,750 shares of LeMaitre Vascular stock in a transaction on Friday, November 15th. The stock was sold at an average price of $101.47, for a total transaction of $380,512.50. Following the completion of the transaction, the director now owns 2,278 shares of the company’s stock, valued at $231,148.66. The trade was a 62.21 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 10.79% of the stock is owned by corporate insiders.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.